MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹5.35 Cr | ₹3.11 Cr | ₹0.50 Cr | ₹0.65 Cr | ₹6.04 Cr |
What is the latest Total Non-Current Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹5.35 Cr |
| Mar2025 | ₹3.11 Cr |
| Mar2024 | ₹0.50 Cr |
| Mar2023 | ₹0.65 Cr |
| Mar2022 | ₹6.04 Cr |
How is Total Non-Current Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.35 Cr | 72.28 | |
| Mar2025 | ₹3.11 Cr | 524.95 | |
| Mar2024 | ₹0.50 Cr | -23.54 | |
| Mar2023 | ₹0.65 Cr | -89.23 | |
| Mar2022 | ₹6.04 Cr | - | |
Compare Total Non-Current Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹359.1 Cr | -4.6% | -20.2% | -18.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -4.6% |
-20.2% |
-18.3% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses